Renascience Inc. Logo

Renascience Inc.

A drug discovery venture developing medicines for diseases of tissue aging.

4889 | T

Overview

Corporate Details

ISIN(s):
JP3981100005
LEI:
Country:
Japan
Address:
仙台市青葉区星陵町2−1

Description

Renascience Inc. is a drug discovery venture originating from Tohoku University. The company focuses on the research and development of various medical modalities, including pharmaceuticals, medical devices, and artificial intelligence (AI) applications. A primary area of its R&D is the study of cellular senescence at the molecular level to develop novel medicines for diseases associated with tissue aging. While initially founded with a focus on kidney disease, Renascience collaborates with academic institutions and corporate partners to advance its diverse R&D pipelines through clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-19 07:34
発行登録追補書類(株券、社債券等)
Japanese ZIP 266.1 KB
2025-12-19 07:32
発行登録追補書類(株券、社債券等)
Japanese ZIP 189.5 KB
2025-12-09 07:34
発行登録追補書類(株券、社債券等)
Japanese ZIP 255.4 KB
2025-12-09 07:33
発行登録追補書類(株券、社債券等)
Japanese ZIP 185.6 KB
2025-11-28 07:32
発行登録書(株券、社債券等)
Japanese ZIP 353.6 KB
2025-11-28 07:31
発行登録書(株券、社債券等)
Japanese ZIP 188.6 KB
2025-11-12 07:39
確認書
Japanese ZIP 8.7 KB
2025-11-12 07:37
半期報告書-第27期(2025/04/01-2026/03/31)
Japanese ZIP 434.5 KB
2025-09-03 08:37
確認書
Japanese ZIP 8.7 KB
2025-09-03 08:30
訂正有価証券報告書-第26期(2024/04/01-2025/03/31)
Japanese ZIP 1.7 MB
2025-06-27 08:35
臨時報告書
Japanese ZIP 23.6 KB
2025-06-24 08:36
内部統制報告書-第26期(2024/04/01-2025/03/31)
Japanese ZIP 23.2 KB
2025-06-24 08:35
確認書
Japanese ZIP 8.7 KB
2025-06-24 08:33
有価証券報告書-第26期(2024/04/01-2025/03/31)
Japanese ZIP 3.5 MB
2024-11-14 07:37
確認書
Japanese ZIP 8.7 KB

Automate Your Workflow. Get a real-time feed of all Renascience Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Renascience Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Renascience Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARTELO BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing therapeutics by modulating the endocannabinoid system.
United States of America
ARTL
Ascelia Pharma Logo
Biotechnology company developing and commercializing novel drugs for orphan oncology.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharmaceutical firm using its prodrug technology to treat rare diseases.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
A clinical-stage biopharma developing novel therapies for cancer and other diseases.
United States of America
AAPG
Specializes in hormone-related pharmaceuticals for internal medicine, OB/GYN, and urology.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Develops sublingual drug delivery technologies for needle-free medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
A clinical-stage biotech developing small molecule antiviral therapeutics for viral diseases.
United States of America
ASMB
Assertio Holdings, Inc. Logo
Pharmaceutical company managing branded products for neurology and orphan diseases.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company turning innovative science into value for patients.
Japan
4503
AstraZeneca PLC Logo
A global, science-led biopharmaceutical company developing prescription medicines.
United Kingdom
AZN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.